CClinicalTrials.gg
CompletedNCT07628790LB-EMS-PilotUpdated Jul 28, 2026

Feasibility of Lower-Body EMS Resistance Training in Postmenopausal Women

An interventional study of Lower-Body EMS combined with Resistance Training and Resistance Training in Post Menopausal, Resistance Exercise and Body Composition, sponsored by Seoul National University. Completed at 1 site in South Korea. Open to female participants aged 50 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by Seoul National University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
50 Years to 70 Years
Sex
Female
01

Study summary

This pilot randomized controlled trial evaluates whether combining lower-body electrical muscle stimulation (EMS) with resistance training is feasible and beneficial for physically inactive postmenopausal women, who experience concurrent declines in muscle strength, body composition, arterial elasticity, and cardiac autonomic balance.

Sixteen physically inactive postmenopausal women aged 50-70 years are randomly assigned (1:1) to either (A) supervised resistance training combined with lower-body EMS (applied to 6 muscle groups: lower back, lower abdomen, glutes, quadriceps, hamstrings, and calves) or (B) supervised resistance training alone. Both groups complete twelve 50-minute sessions (consisting of a 10-minute warm-up, 30-minute main exercise, and a 10-minute cool-down) over 6 weeks (twice weekly). Assessments before and after the intervention include body composition, lower-body muscle function, arterial stiffness, and 5-minute heart rate variability.

The primary aim is to determine the feasibility of the protocol(recruitment, retention, session attendance, and intervention dose delivery) to inform a future definitive trial. Preliminary estimates of intervention effects on the measured outcomes are reported as secondary aims.

Read the detailed description

BACKGROUND AND RATIONALE Postmenopausal women often experience physiological declines in muscle function, body composition, and cardiovascular health. While resistance training is an established countermeasure, maximizing its efficiency and adherence remains a challenge. Applying lower-body electrical muscle stimulation (EMS) during resistance training may enhance physiological adaptations and overall training effectiveness. This study aims to evaluate the feasibility of combining lower-body EMS with resistance training in physically inactive postmenopausal women to inform the design of a future definitive trial.

STUDY DESIGN This is a pilot randomized controlled trial. Participants will be randomly assigned to either an intervention group receiving combined lower-body EMS and resistance training or a control group receiving resistance training alone. Clinical and physiological outcomes will be assessed before and after the intervention period to evaluate preliminary effects.

PRIMARY FEASIBILITY OUTCOMES

The primary objective is to evaluate the feasibility of the study protocol. Feasibility will be determined by assessing several key components, including:

Recruitment: The ability to recruit the target population within the planned timeframe.

Retention: The proportion of participants who complete the study and post-intervention assessments.

Adherence: Participant attendance and compliance with the scheduled exercise sessions.

Intervention Fidelity: The successful delivery of the exercise intensity and EMS protocol as intended.

These components will be evaluated against pre-established progression criteria to determine whether the protocol can proceed to a larger trial or requires modification.

STATISTICAL APPROACH Feasibility outcomes will be summarized primarily using descriptive statistics. For secondary physiological and clinical outcomes, appropriate statistical methods will be utilized to estimate the preliminary effects of the intervention, comparing changes between the groups while adjusting for baseline measurements. Effect sizes and confidence intervals will be calculated to provide preliminary evidence and to assist with sample size calculations for future large-scale trials.

02

Conditions studied

  • Post Menopausal
  • Resistance Exercise
  • Body Composition
  • Autonomic Function

Browse trials for

Keywords

  • Electrical Muscle Stimulation
  • Resistance Training
  • Exercise
  • Lower Body
  • Neuromuscular Electrical Stimulation
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's enrollment of 16 is below the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Seoul National University is the lead sponsor of 30 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Women aged 50 to 70 years.
  • Menopause for at least 1 year with no current menstruation.
  • Physically inactive (have not participated in resistance training more than twice a week for the past 6 months)

Exclusion criteria

Exclusion Criteria:

  • Currently receiving hormone replacement therapy (HRT).
  • Presence of implanted electrical medical devices.
  • Severe or uncontrolled medical conditions.
  • Any surgery within the past 6 months.
  • Acute illness with fever, infection, or active inflammation.
  • Severe peripheral arterial disease or abdominal/inguinal hernia.
  • Severe psychiatric disorders requiring medication, or current substance abuse.
  • Deemed physically or mentally unfit to participate in the exercise program by the investigator.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    A Group: EMS + Resistance Training

    Lower-body EMS combined with 8 machine-based resistance exercises for 6 weeks, 2 sessions per week.

    Device: Lower-Body EMS combined with Resistance Training · Behavioral: Resistance Training

  • Active comparator
    B Group: Resistance Training

    8 machine-based resistance exercises for 6 weeks, 2 sessions per week without EMS.

    Behavioral: Resistance Training

Interventions

  • DeviceLower-Body EMS combined with Resistance Training

    Electrical muscle stimulation (85 Hz, 350 μs, cycle 11, duty approx 1:2) applied to 6 muscle groups: lower back (erector spinae), lower abdomen, glutes, quadriceps, hamstrings, and calves.

  • BehavioralResistance Training

    A 50-minute session consisting of a 10-minute warm-up, 30 minutes of main exercise (8 machine-based lower-body resistance exercises, 3 sets of 8-12 repetitions), and a 10-minute cool-down.

06

What researchers measure

Primary outcomes

  1. Composite Feasibility Outcome (Recruitment, Retention, Session Attendance, and Intervention Dose Delivery)

    The primary outcome is the feasibility of the study protocol, assessed via recruitment rates, participant retention, session adherence, and targeted intervention delivery. These indicators will be evaluated against pre-defined progression criteria using descriptive statistics to determine whether to proceed with or modify the protocol for a future definitive trial. Unit: Percentage

    Time frame: Baseline and Week 6

Secondary outcomes

  1. Skeletal Muscle Mass Index (SMI)

    Appendicular skeletal muscle mass divided by height squared. Unit: kg/m².

    Time frame: Baseline and Week 6

  2. Total Body Muscle Mass

    Total skeletal muscle mass of the whole body. Unit: kg

    Time frame: Baseline and Week 6

  3. Total Leg Muscle Mass

    Combined left and right leg skeletal muscle mass. Unit: kg

    Time frame: Baseline and Week 6

  4. Body Fat Percentage

    Body fat mass expressed as a percentage of total body weight. Unit: %

    Time frame: Baseline and Week 6

  5. Total Body Fat Mass

    Absolute total body fat in kilograms. Unit: kg

    Time frame: Baseline and Week 6

  6. Estimated Visceral Fat Area (eVFA)

    Estimated visceral fat area at the umbilical level. Unit: cm²

    Time frame: Baseline and Week 6

  7. Waist Circumference

    Circumference measured at the level of the umbilicus. Unit: cm

    Time frame: Baseline and Week 6

  8. Waist-to-Hip Ratio (WHR)

    Waist circumference divided by hip circumference. Unit: ratio

    Time frame: Baseline and Week 6

  9. Body Mass Index (BMI)

    Body weight in kilograms divided by the square of height in meters. Unit: kg/m²

    Time frame: Baseline and Week 6

  10. Phase Angle

    Whole-body bioimpedance phase angle derived from the arctangent of the reactance-to-resistance ratio. Marker of cellular membrane integrity and overall nutritional/health status. Unit: degrees

    Time frame: Baseline and Week 6

  11. Dominant Knee Extensor Peak Torque per Body Weight at 60°/s

    Peak concentric knee extensor torque normalized to body weight, measured at 60°/sec angular velocity on the dominant limb. Unit: Nm/kg

    Time frame: Baseline and Week 6

  12. Non-dominant Knee Extensor Peak Torque per Body Weight at 60°/s

    Peak concentric knee extensor torque normalized to body weight at 60°/sec on the non-dominant limb. Unit: Nm/kg

    Time frame: Baseline and Week 6

  13. Dominant Knee Flexor Peak Torque per Body Weight at 60°/s

    Peak concentric knee flexor (hamstring) torque normalized to body weight at 60°/sec on the dominant limb. Unit: Nm/kg

    Time frame: Baseline and Week 6

  14. Non-dominant Knee Flexor Peak Torque per Body Weight at 60°/s

    Peak concentric knee flexor torque normalized to body weight at 60°/sec on the non-dominant limb. Unit: Nm/kg

    Time frame: Baseline and Week 6

  15. Dominant Hamstring-to-Quadriceps (H/Q) Ratio at 60°/s

    Ratio of knee flexor peak torque to knee extensor peak torque at 60°/sec on the dominant limb. Unit: ratio

    Time frame: Baseline and Week 6

  16. Non-dominant Hamstring-to-Quadriceps (H/Q) Ratio at 60°/s

    Ratio of knee flexor peak torque to knee extensor peak torque at 60°/sec on the non-dominant limb. Unit: ratio

    Time frame: Baseline and Week 6

  17. Dominant Total Work Done by Knee Extensor per Body Weight at 180°/s

    Total work performed by knee extensors across the test set, normalized to body weight, at 180°/sec angular velocity on the dominant limb. Unit: Nm/kg

    Time frame: Baseline and Week 6

  18. Non-dominant Total Work Done by Knee Extensor per Body Weight at 180°/s

    Total work performed by knee extensors normalized to body weight at 180°/sec on the non-dominant limb. Unit: Nm/kg

    Time frame: Baseline and Week 6

  19. Dominant Total Work Done by Knee Flexor per Body Weight at 180°/s

    Total work performed by knee flexors normalized to body weight at 180°/sec on the dominant limb. Unit: Nm/kg

    Time frame: Baseline and Week 6

  20. Non-dominant Total Work Done by Knee Flexor per Body Weight at 180°/s

    Total work performed by knee flexors normalized to body weight at 180°/sec on the non-dominant limb. Unit: Nm/kg

    Time frame: Baseline and Week 6

  21. Average Brachial-Ankle Pulse Wave Velocity (baPWV)

    Mean of left and right brachial-ankle pulse wave velocity; primary indicator of large-artery stiffness. Unit: cm/s

    Time frame: Baseline and Week 6

  22. Highest Brachial-Ankle Pulse Wave Velocity (baPWV)

    The higher of left and right baPWV values, reflecting the most affected limb. Unit: cm/s

    Time frame: Baseline and Week 6

  23. Brachial Systolic Blood Pressure (SBP)

    Brachial systolic blood pressure. Unit: mmHg

    Time frame: Baseline and Week 6

  24. Brachial Diastolic Blood Pressure (DBP)

    Brachial diastolic blood pressure. Unit: mmHg

    Time frame: Baseline and Week 6

  25. Pulse Pressure (PP)

    Pulse pressure calculated as systolic minus diastolic blood pressure. Unit: mmHg

    Time frame: Baseline and Week 6

  26. Mean Arterial Pressure (MAP)

    Mean arterial pressure derived from systolic and diastolic blood pressure. Unit: mmHg

    Time frame: Baseline and Week 6

  27. Average Ankle-Brachial Index (ABI)

    Mean of left and right ankle-brachial systolic blood pressure ratio. Unit: ratio

    Time frame: Baseline and Week 6

  28. Augmentation Index (AI)

    Augmentation index derived from second-derivative photoplethysmography. Unit: unitless

    Time frame: Baseline and Week 6

  29. Root Mean Square of Successive Differences (RMSSD)

    Root mean square of successive differences between adjacent normal-to-normal RR intervals. Unit: ms

    Time frame: Baseline and Week 6

  30. High-Frequency (HF) Power

    Spectral power in the high-frequency band (0.15-0.4 Hz); index of parasympathetic (vagal) activity. Unit: ms²

    Time frame: Baseline and Week 6

  31. Standard Deviation of NN Intervals (SDNN)

    Standard deviation of all normal-to-normal RR intervals; time-domain index of overall heart rate variability. Unit: ms

    Time frame: Baseline and Week 6

  32. Low-Frequency (LF) Power

    Spectral power in the low-frequency band (0.04-0.15 Hz). Unit: ms²

    Time frame: Baseline and Week 6

  33. LF/HF Ratio

    Ratio of low-frequency to high-frequency spectral power. Unit: ratio

    Time frame: Baseline and Week 6

  34. High-Frequency Normalized Units (HFnu)

    HF power expressed in normalized units = HF / (LF + HF) × 100. Unit: n.u.

    Time frame: Baseline and Week 6

  35. Low-Frequency Normalized Units (LFnu)

    LF power expressed in normalized units = LF / (LF + HF) × 100. Unit: n.u.

    Time frame: Baseline and Week 6

  36. Total Power (TP)

    Total spectral power up to 0.4 Hz. Unit: ms²

    Time frame: Baseline and Week 6

  37. Very-Low-Frequency (VLF) Power

    Spectral power in the very-low-frequency band (≤0.04 Hz). Unit: ms²

    Time frame: Baseline and Week 6

Other outcomes

  1. Dominant Knee Extensor Fatigue Index at 180°/s

    Percentage decline in knee extensor torque across the repetition set at 180°/sec on the dominant limb. Unit: %

    Time frame: Baseline and Week 6

  2. Non-dominant Knee Extensor Fatigue Index at 180°/s

    Percentage decline in knee extensor torque across the repetition set at 180°/sec on the non-dominant limb. Unit: %

    Time frame: Baseline and Week 6

  3. Dominant Knee Flexor Fatigue Index at 180°/s

    Percentage decline in knee flexor torque across the repetition set at 180°/sec on the dominant limb. Unit: %.

    Time frame: Baseline and Week 6

  4. Non-dominant Knee Flexor Fatigue Index at 180°/s

    Percentage decline in knee flexor torque across the repetition set at 180°/sec on the non-dominant limb. Unit: %

    Time frame: Baseline and Week 6

  5. Bilateral Deficit of Knee Extensors at 60°/s

    Percentage asymmetry of knee extensor peak torque between dominant and non-dominant limbs at 60°/sec. Unit: %

    Time frame: Baseline and Week 6

  6. Bilateral Deficit of Knee Flexors at 60°/s

    Percentage asymmetry of knee flexor peak torque between dominant and non-dominant limbs at 60°/sec. Unit: %

    Time frame: Baseline and Week 6

  7. Dominant Total Work Done H/Q Ratio at 180°/s

    Ratio of knee flexor to knee extensor total work done at 180°/sec on the dominant limb. Unit: ratio

    Time frame: Baseline and Week 6

  8. Non-dominant Total Work Done H/Q Ratio at 180°/s

    Ratio of knee flexor to knee extensor total work done at 180°/sec on the non-dominant limb. Unit: ratio

    Time frame: Baseline and Week 6

  9. Arterial Elasticity (AE)

    Arterial elasticity index derived from second-derivative photoplethysmography. Unit: unitless

    Time frame: Baseline and Week 6

  10. Peripheral Elasticity (PE)

    Peripheral elasticity index derived from second-derivative photoplethysmography. Unit: unitless.

    Time frame: Baseline and Week 6

07

Study locations

1 site
  • Seoul National University
    Seoul, Seoul 08826, South Korea
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07628790
Lead sponsor
Seoul National University
Responsible party
Kyungho Kim (Researcher, Seoul National University) — Principal investigator
First posted
Jun 5, 2026
Start date
Jun 1, 2026
Primary completion
Jul 27, 2026
Completion
Jul 27, 2026
Last update
Jul 28, 2026

Study contacts

Yeon Soo Kim, MD, Prof
principal investigator · Seoul National University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion